Cover Image
市場調查報告書

全球免疫球蛋白市場產品、開發平台分析

A Product and Pipeline Analysis of the Global Immunoglobulin Market

出版商 Frost & Sullivan 商品編碼 341670
出版日期 內容資訊 英文 72 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球免疫球蛋白市場產品、開發平台分析 A Product and Pipeline Analysis of the Global Immunoglobulin Market
出版日期: 2015年09月30日 內容資訊: 英文 72 Pages
簡介

本報告提供免疫球蛋白市場上市、開發中產品調查分析、市場概要、市場分析、主要產品、主要企業等相關的系統性資訊。

第1章 摘要整理

第2章 免疫球蛋白市場概要

  • 免疫球蛋白概要
  • 免疫球蛋白的分類
  • 治療指南
  • 市場概要

第3章 免疫球蛋白市場:上市、開發中產品

  • 醫藥品概要
  • 競爭情形:傳染性疾病的治療
  • 競爭情形:非傳染性疾病的治療

第4章 傳染性疾病產品分析

  • 傳染性疾病產品概要
  • 上市產品分析
  • 開發中產品分析

第5章 非傳染性疾病產品分析

  • 非傳染性疾病產品概要
  • 上市產品分析
  • 開發中產品分析

第6章 免疫球蛋白市場:產品開發動態即時看板系統

  • Hizentra:CSL Behring
  • Civacir:Biotest
  • Flebogamma 10%:Grifols
  • GAMUNEX-C:Grifols
  • Privigen:CSL Behring
  • VariZIG:Cangene
  • Hepabulin IV:SK Holdings
  • Zutectra:Biotest
  • HyperTET:Grifols

第7章 免疫球蛋白市場主要企業

  • Baxter International Inc.
  • Biotest AG
  • China Biologics Products, Inc.
  • CSL Behring Limited
  • Grifols
  • Octapharma AG
  • Kedrion Biopharma

第8章 免疫球蛋白市場:主要活動的時間軸

  • 主要產品銷售的時間軸
  • 核准年月日

第9章 免疫球蛋白市場未來

  • 結論
  • 免責聲明

第10章 關於Frost&Sullivan

目錄
Product Code: P8C1-01-00-00-00

Trends in Communicable and Non-Communicable Diseases Drug Pipeline

Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global demand for immunoglobulin is growing and the market is expected to foresee increased competition. As of 2015, more than 40 immunoglobulin treatments have been approved, with another 28 in various stages of development. This research service provides an overview of the marketed products and those in the pipeline. The analysis divides these treatments by the communicable and non-communicable diseases that they treat. In addition, key products and companies are profiled.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Major Milestones
  • 4. Major Milestones (continued)
  • 5. Scope of the Study

2. INTRODUCTION TO THE IMMUNOGLOBULIN MARKET

  • 1. Immunoglobulin Overview
  • 2. Classification of Immunoglobulins
  • 3. Classification of Immunoglobulins (continued)
  • 4. Treatment Guidelines
  • 5. Treatment Guidelines (continued)
  • 6. Market Overview
  • 7. Market Overview (continued)
  • 8. Market Overview (continued)

3. IMMUNOGLOBULIN MARKET-MARKETED AND PIPELINE PRODUCTS

  • 1. Overview of Drugs
  • 2. Overview of Drugs (continued)
  • 3. Competitive Landscape-Communicable Diseases Treatments
  • 4. Competitive Landscape-Non-Communicable Diseases Treatments

4. COMMUNICABLE DISEASES PRODUCT ANALYSIS

  • 1. Communicable Diseases Product Overview
  • 2. Marketed Product Analysis
  • 3. Marketed Product Analysis (continued)
  • 4. Marketed Product Analysis (continued)
  • 5. Marketed Product Analysis (continued)
  • 6. Marketed Product Analysis (continued)
  • 7. Marketed Product Analysis (continued)
  • 8. Pipeline Product Analysis
  • 9. Pipeline Product Analysis (continued)

5. NON-COMMUNICABLE DISEASES PRODUCT ANALYSIS

  • 1. Non-Communicable Diseases Product Overview
  • 2. Marketed Product Analysis
  • 3. Marketed Product Analysis (continued)
  • 4. Marketed Product Analysis (continued)
  • 5. Pipeline Product Analysis
  • 6. Pipeline Product Analysis (continued)

6. IMMUNOGLOBULIN MARKET-PRODUCT DASHBOARDS

  • 1. Hizentra-CSL Behring
  • 2. Civacir-Biotest
  • 3. Flebogamma 10%-Grifols
  • 4. GAMUNEX-C-Grifols
  • 5. Privigen-CSL Behring
  • 6. VariZIG-Cangene
  • 7. Hepabulin IV-SK Holdings
  • 8. Zutectra-Biotest
  • 9. HyperTET-Grifols

7. KEY COMPANIES IN THE IMMUNOGLOBULIN MARKET

  • 1. Baxter International Inc.
  • 2. Biotest AG
  • 3. China Biologics Products, Inc.
  • 4. CSL Behring Limited
  • 5. Grifols
  • 6. Octapharma AG
  • 7. Kedrion Biopharma

8. IMMUNOGLOBULIN MARKET-TIMELINE OF KEY EVENTS

  • 1. Estimated Key Product Launch Timeline
  • 2. Approval Dates

9. FUTURE OF THE IMMUNOGLOBULIN MARKET

  • 1. Conclusions-Future of Immunoglobulin Market
  • 2. Legal Disclaimer

10. THE FROST & SULLIVAN STORY

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top